These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28583690)

  • 1. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
    Luque Ramos A; Hoffmann F; Albrecht K; Klotsche J; Zink A; Minden K
    Semin Arthritis Rheum; 2017 Oct; 47(2):269-275. PubMed ID: 28583690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care].
    Niewerth M; Minden K; Klotsche J; Horneff G
    Z Rheumatol; 2014 Aug; 73(6):532-40. PubMed ID: 25096586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of transition phase patients with juvenile idiopathic arthritis.
    Relas H; Luosujärvi R; Kosola S
    Mod Rheumatol; 2018 Sep; 28(5):832-837. PubMed ID: 29251024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.
    McMahan R; Balfe LM; Greene L
    J Manag Care Pharm; 2012; 18(1 Suppl B):1-16. PubMed ID: 22376227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies.
    Vidqvist KL; Malin M; Varjolahti-Lehtinen T; Korpela MM
    Rheumatology (Oxford); 2013 Nov; 52(11):1999-2003. PubMed ID: 23893666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan.
    Miyamae T; Tanaka E; Kishi T; Matsuyama T; Igarashi T; Fujikawa S; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2015 Jan; 25(1):62-6. PubMed ID: 25019624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study.
    Grazziotin LR; Currie G; Twilt M; Ijzerman MJ; Kip MMA; Koffijberg H; Benseler SM; Swart JF; Vastert SJ; Wulffraat NM; Yeung RSM; Marshall DA
    Pediatr Rheumatol Online J; 2022 Apr; 20(1):25. PubMed ID: 35410419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis.
    Lee WJ; Briars L; Lee TA; Calip GS; Suda KJ; Schumock GT
    Pharmacotherapy; 2016 Dec; 36(12):1201-1209. PubMed ID: 27779782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis.
    Sener S; Aliyev E; Batu ED; Balik Z; Bayindir Y; Cam V; Basaran O; Bilginer Y; Ozen S
    Clin Rheumatol; 2024 Jun; 43(6):2021-2026. PubMed ID: 38683443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease.
    Relas H; Kosola S
    Clin Rheumatol; 2019 Mar; 38(3):785-791. PubMed ID: 30374749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort.
    Zamora-Legoff JA; Krause ML; Crowson CS; Muskardin TW; Mason T; Matteson EL
    Clin Rheumatol; 2016 Jun; 35(6):1493-9. PubMed ID: 26825065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
    Tappeiner C; Schenck S; Niewerth M; Heiligenhaus A; Minden K; Klotsche J
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):46-54. PubMed ID: 26212111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry.
    Migowa AN; Hamdi W; Hashad S; Etayari H; Abushhaiwia A; Ferjani H; Nessib DB; Kharrat L; Fazaa A; Owino L; Faleye A; Owusu SA; Mosa DM; Eissa M; Nasef SI; Elsehrawy GG; Odhiambo R; Orwa J; Abu-Zaid MH
    Pediatr Rheumatol Online J; 2024 Jul; 22(1):67. PubMed ID: 39039515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological/social factors associated with transfer readiness in young people with juvenile idiopathic arthritis.
    Howsley P; Dunkley L; Calvert R; Hawley S; Tattersall R; McMahon AM; Hawley D
    Clin Rheumatol; 2022 Dec; 41(12):3777-3782. PubMed ID: 35896902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease activity and dropout in young persons with juvenile idiopathic arthritis in transition of care: a longitudinal observational study.
    van Pelt PA; Dolhain RJEM; Kruize AA; Ammerlaan JJW; Hazes JW; Bijlsma JWJ; Wulffraat NM
    Clin Exp Rheumatol; 2018; 36(1):163-168. PubMed ID: 29461957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome in juvenile idiopathic arthritis: a population-based study from Sweden.
    Berthold E; Månsson B; Kahn R
    Arthritis Res Ther; 2019 Oct; 21(1):218. PubMed ID: 31661011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis.
    Horneff G; Klein A; Ganser G; Sailer-Höck M; Günther A; Foeldvari I; Weller-Heinemann F
    Pediatr Rheumatol Online J; 2017 Nov; 15(1):78. PubMed ID: 29116003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013.
    Klotsche J; Raab A; Niewerth M; Sengler C; Ganser G; Kallinich T; Niehues T; Hufnagel M; Thon A; Hospach T; Horneff G; Minden K
    Arthritis Rheumatol; 2016 Dec; 68(12):3023-3034. PubMed ID: 27332999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
    Guzman J; Oen K; Tucker LB; Huber AM; Shiff N; Boire G; Scuccimarri R; Berard R; Tse SM; Morishita K; Stringer E; Johnson N; Levy DM; Duffy KW; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey S; Bruns A; Campillo S; Benseler S; Chédeville G; Schneider R; Yeung R; Duffy CM;
    Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis-results from a JIA biologic registry.
    Drechsel P; Stüdemann K; Niewerth M; Horneff G; Fischer-Betz R; Seipelt E; Spähtling-Mestekemper S; Aries P; Zink A; Klotsche J; Minden K
    Rheumatology (Oxford); 2020 Mar; 59(3):603-612. PubMed ID: 31412128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.